RxDoctor Payments Data

Manish Vira, MD

Urology · New Hyde Park, NYNPI 1407054398

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (43.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Bayer at 43.9% of the total. Reporting peaked in 2022 at $609 and has fallen 84.5% since, to $94 in 2025. That places this record below the midpoint for urology clinicians in NY, where the typical reported total is $2,467.

$1,389in general payments, 2019–2025

Across 13 payments — averaging $106.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$609
  • Merck$603
  • Medtronic$89
  • Pfizer$35
  • Activ Surgical, Inc.$26
  • Procept Biorobotics Corporation$21
  • plus $6 from 1 others
$2,128,621in research payments, 2019–2025

Across 224 payments — averaging $9502.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$2M
  • Histosonics, Inc.$86K
  • Ferring Pharmaceuticals AS$61K
  • Organon$3K

What the payments were for

  • Consulting fees$60944%
  • Travel & lodging$50536%
  • Food & beverage$23517%
  • Education$403%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,389 in reported general payments places this provider in the 40th percentile of 952 urology providers in New York.

See all urology providers in New York

Medicare billing

Part B allowed, 2024
$205,400
Medicare patients
597
Services billed
1,804

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron44$46,959
Methenamine Hippurate66$6,567
Tamsulosin Hcl414$6,206
Finasteride366$4,734
Trospium Chloride73$4,420
Oxybutynin Chloride ErOxybutynin Chloride160$4,052
Solifenacin Succinate35$3,878
Alfuzosin Hcl ErAlfuzosin Hcl88$2,874
Potassium Citrate ErPotassium Citrate16$1,441
Cephalexin16$644
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip25$467
Sildenafil Citrate13$352
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$153
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$57
Diazepam15$7

Paid to pharmacies, not to this prescriber.

Other urology in New Hyde Park

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →